TrialCell reports. Medicine2023

Cancer stem cell assay-guided chemotherapy improves survival of patients with recurrent glioblastoma in a randomized trial.

Tulika Ranjan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.